PURPOSE: The American Society of Clinical Oncology Quality Oncology Practice Initiative (QOPI) has provided a method for measuring process-based practice quality since 2006. We sought to determine whether QOPI scores showed improvement in measured quality over time and, if change was demonstrated, which factors in either the measures or participants were associated with improvement. METHODS: The analysis included 156 practice groups from a larger group of 308 that submitted data from 2006 to 2010. One hundred fifty-two otherwise eligible practices were excluded, most commonly for insufficient data submission. A linear regression model that controlled for varied initial performance was used to estimate the effect of participation over time and evaluate participant and measure characteristics of improvement. RESULTS: Participants completed a mean of 5.06 (standard deviation, 1.94) rounds of data collection. Adjusted mean quality scores improved from 0.71 (95% CI, 0.42 to 0.91) to 0.85 (95% CI, 0.60 to 0.95). Overall odds ratio of improvement over time was 1.09 (P < .001). The greatest improvement was seen in measures that assessed newly introduced clinical information, in which the mean scores improved from 0.05 (95% CI, 0.01 to 0.17) to 0.69 (95% CI, 0.33 to 0.91; P < .001). Many measures showed no change over time. CONCLUSION: Many US oncologists have participated in QOPI over the past 6 years. Participation over time was highly correlated with improvement in measured performance. Greater and faster improvement was seen in measures concerning newly introduced clinical information. Some measures showed no change despite opportunity for improvement.
PURPOSE: The American Society of Clinical Oncology Quality Oncology Practice Initiative (QOPI) has provided a method for measuring process-based practice quality since 2006. We sought to determine whether QOPI scores showed improvement in measured quality over time and, if change was demonstrated, which factors in either the measures or participants were associated with improvement. METHODS: The analysis included 156 practice groups from a larger group of 308 that submitted data from 2006 to 2010. One hundred fifty-two otherwise eligible practices were excluded, most commonly for insufficient data submission. A linear regression model that controlled for varied initial performance was used to estimate the effect of participation over time and evaluate participant and measure characteristics of improvement. RESULTS:Participants completed a mean of 5.06 (standard deviation, 1.94) rounds of data collection. Adjusted mean quality scores improved from 0.71 (95% CI, 0.42 to 0.91) to 0.85 (95% CI, 0.60 to 0.95). Overall odds ratio of improvement over time was 1.09 (P < .001). The greatest improvement was seen in measures that assessed newly introduced clinical information, in which the mean scores improved from 0.05 (95% CI, 0.01 to 0.17) to 0.69 (95% CI, 0.33 to 0.91; P < .001). Many measures showed no change over time. CONCLUSION: Many US oncologists have participated in QOPI over the past 6 years. Participation over time was highly correlated with improvement in measured performance. Greater and faster improvement was seen in measures concerning newly introduced clinical information. Some measures showed no change despite opportunity for improvement.
Authors: Angela M Stover; Benjamin Y Urick; Allison M Deal; Randall Teal; Maihan B Vu; Jessica Carda-Auten; Jennifer Jansen; Arlene E Chung; Antonia V Bennett; Anne Chiang; Charles Cleeland; Yehuda Deutsch; Edmund Tai; Dylan Zylla; Loretta A Williams; Collette Pitzen; Claire Snyder; Bryce Reeve; Tenbroeck Smith; Kristen McNiff; David Cella; Michael N Neuss; Robert Miller; Thomas M Atkinson; Patricia A Spears; Mary Lou Smith; Cindy Geoghegan; Ethan M Basch Journal: JCO Oncol Pract Date: 2020-02-19
Authors: Robert D Siegel; Kathleen M Castro; Jana Eisenstein; Holley Stallings; Patricia D Hegedus; Donna M Bryant; Pam J Kadlubek; Steven B Clauser Journal: J Oncol Pract Date: 2014-12-23 Impact factor: 3.840
Authors: Paul B Jacobsen; Ji-Hyun Lee; William Fulp; Erin M Siegel; David Shibata; Christine Laronga; Jhanelle Gray; Tawee Tanvetyanon; Fred Schreiber; Richard Brown; Richard Levine; Thomas Cartwright; Guillermo Abesada-Terk; George Kim; Carlos Alemany; Douglas Faig; Philip Sharp; Merry-Jennifer Markham; Mokenge Malafa Journal: J Oncol Pract Date: 2014-10-28 Impact factor: 3.840
Authors: Gwendolyn P Quinn; Rebecca G Block; Marla L Clayman; Joanne Kelvin; Sarah R Arvey; Ji-Hyun Lee; Joyce Reinecke; Ivana Sehovic; Paul B Jacobsen; Damon Reed; Luis Gonzalez; Susan T Vadaparampil; Christine Laronga; M Catherine Lee; Julio Pow-Sang; Susan Eggly; Anna Franklin; Bijal Shah; William J Fulp; Brandon Hayes-Lattin Journal: J Oncol Pract Date: 2014-12-30 Impact factor: 3.840
Authors: Christine Laronga; Jhanelle E Gray; Erin M Siegel; Ji-Hyun Lee; William J Fulp; Michelle Fletcher; Fred Schreiber; Richard Brown; Richard Levine; Thomas Cartwright; Guillermo Abesada-Terk; George Kim; Carlos Alemany; Douglas Faig; Phillip Sharp; Merry-Jennifer Markham; David Shibata; Mokenge Malafa; Paul B Jacobsen Journal: J Am Coll Surg Date: 2014-07-01 Impact factor: 6.113